Research Article
[Retracted] The Expression of miR-205 in Prostate Carcinoma and the Relationship with Prognosis in Patients
Table 2
Univariate and multivariate analysis of overall survival in patients with prostate cancer (
).
| Variable for overall survival | Univariate analysis | Multivariate analysis | HR | 95% CI | | HR | 95% CI | |
| Age(years) | | | 0.897 | | | | ≤60 vs. >60 | 1.043 | 0.547-1.989 | | | | | Lymph node metastasis | | | 0.071 | | | | Negative vs. positive | 1.819 | 0.950-3.485 | | | | | Distant metastasis | | | 0.218 | | | | M0 vs. M1 | 1.501 | 0.786-2.863 | | | | | Tumor stage | | | 0.011 | | | 0.105 | ≤T2 vs. >T2 | 2.364 | 1.220-4.580 | | 0.565 | 0.283-1.128 | | PSA at initial diagnosis (ng/mL) | | 0.008 | | | 0.294 | ≤20 vs. >20 | 2.45 | 1.263-4.754 | | 0.671 | 0.318-1.414 | | miR-205 expression | | | | | | 0.021 | Low vs. high | 3.251 | 1.675-6.313 | | 0.417 | 0.198-0.878 | |
|
|